| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/1994 | US5288639 Purified candidal stress protein or immunogenic epitope or homolog thereof |
| 02/22/1994 | US5288630 For preparing specific immune responses against human respiratory syncytial virus |
| 02/22/1994 | US5288629 Anticoagulants |
| 02/22/1994 | US5288628 Rat osteosarcoma cell line OSR4TR1 |
| 02/22/1994 | US5288623 Process for secretory production of a calcium-binding protein |
| 02/22/1994 | US5288622 Human nerve growth factor by recombinant technology |
| 02/22/1994 | US5288621 Pituitary TRH receptor |
| 02/22/1994 | US5288617 Method of producing an antigenic preparation |
| 02/22/1994 | US5288607 Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides |
| 02/22/1994 | US5288490 Anticoagulants having no side effects; immobilizing on the surface of the thrombus to effect lysis |
| 02/22/1994 | CA2104043A1 Melanin formation-inhibitory protein, and its preparation and uses |
| 02/22/1994 | CA1327176C Coleopteran-active bacillus thuringiensis isolate |
| 02/22/1994 | CA1327172C Production of human epidermal growth factor |
| 02/22/1994 | CA1327171C Recombinant human cytomegalovirus containing foreign gene and use thereof |
| 02/22/1994 | CA1327168C Anti-trichomonas vaginalis monoclonal antibodies |
| 02/22/1994 | CA1327162C Method for prophylactically treating an individual for an autoimmune disease |
| 02/17/1994 | WO1994003813A1 Immunoassay for detecting collagen or collagen fragments |
| 02/17/1994 | WO1994003810A1 Method for detecting mycoplasmic infections |
| 02/17/1994 | WO1994003806A1 Immunochemical assays for cancer-associated scm recognition factor |
| 02/17/1994 | WO1994003644A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | WO1994003633A1 Assessment of trans-acting factors allelic variation |
| 02/17/1994 | WO1994003628A1 Recombinant equine herpesviruses |
| 02/17/1994 | WO1994003627A1 Method for design of novel proteins and proteins produced thereby |
| 02/17/1994 | WO1994003626A1 Method of highly purifying human serum albumin |
| 02/17/1994 | WO1994003622A1 D-type retroviral vectors, based on mpmv |
| 02/17/1994 | WO1994003621A1 Vector vaccines of recombinant feline herpesvirus |
| 02/17/1994 | WO1994003620A2 Method of increasing expression of viral proteins |
| 02/17/1994 | WO1994003618A1 K. lactis transaldolase gene promoter and use thereof |
| 02/17/1994 | WO1994003617A1 Process for producing anti-freeze peptides |
| 02/17/1994 | WO1994003615A1 Expression of recombinant fusion proteins in attenuated bacteria |
| 02/17/1994 | WO1994003610A2 Isolation and cloning of a protein with tyrosine-phosphatase activity |
| 02/17/1994 | WO1994003608A1 Hypoglycosylated recombinant glucosidase oxidases |
| 02/17/1994 | WO1994003605A2 Compositions and methods for detecting human herpesvirus 6 strain z29 |
| 02/17/1994 | WO1994003604A1 PfEMP3 MALARIA ANTIGEN, ANALOGS, ANTIBODIES AND USES THEREOF |
| 02/17/1994 | WO1994003603A1 Novel glycoforms of soluble complement receptor 1 |
| 02/17/1994 | WO1994003602A2 A novel human dopamine receptor and its uses |
| 02/17/1994 | WO1994003601A2 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 02/17/1994 | WO1994003600A1 Morphogenic protein soluble complex and composition thereof |
| 02/17/1994 | WO1994003599A1 HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR |
| 02/17/1994 | WO1994003598A1 Antiallergic agent |
| 02/17/1994 | WO1994003597A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | WO1994003596A1 Antisense viruses and antisense-ribozyme viruses |
| 02/17/1994 | WO1994003595A1 Non-shedding live herpesvirus vaccine |
| 02/17/1994 | WO1994003594A1 Androgen regulation with dna sequences of rat probasin gene |
| 02/17/1994 | WO1994003585A1 A method for maintaining embryonic stem cells and avian factor useful for same |
| 02/17/1994 | WO1994003494A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | WO1994003493A1 Peptides derived from an immunosuppressive region in the retroviral genome |
| 02/17/1994 | WO1994003492A1 Interleukin-6 variants and uses therefor |
| 02/17/1994 | WO1994003491A1 Amylin muteins |
| 02/17/1994 | WO1994003490A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 02/17/1994 | WO1994003489A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 02/17/1994 | WO1994003488A1 Novel peptide |
| 02/17/1994 | WO1994003487A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 02/17/1994 | WO1994003486A1 Labeled charybdotoxin |
| 02/17/1994 | WO1994003484A1 Synthetic peptide lung surfactants having covalently bonded antioxidants |
| 02/17/1994 | WO1994003483A1 Endothelin receptor-binding compounds |
| 02/17/1994 | WO1994003481A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | WO1994003478A1 Sensitive assay for antigens and antibodies and its use to identify rheumatoid arthritis antigen |
| 02/17/1994 | WO1994003477A1 Salicylic acid binding protein |
| 02/17/1994 | WO1994003472A1 Nucleic acid sequence amplification |
| 02/17/1994 | WO1994003208A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 02/17/1994 | WO1994003207A1 Herpesvirus vaccines |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003201A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | WO1994003200A1 Morphogen-induced nerve regeneration and repair |
| 02/17/1994 | WO1994003197A1 Pharmaceuticals containing onconase and cisplatin, melphalan and adriamycin |
| 02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | WO1994003191A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 02/17/1994 | WO1994003075A2 Morphogen-enriched dietary composition |
| 02/17/1994 | WO1994003059A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 02/17/1994 | WO1994003047A1 Constitutive triple response gene and mutations |
| 02/17/1994 | WO1994000599A3 Process for detection of neoplastic disease |
| 02/17/1994 | WO1994000587A3 Attenuated equine herpesvirus-4 as live vaccine or recombinant vector |
| 02/17/1994 | WO1994000586A3 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 02/17/1994 | WO1994000582A3 A method for obtaining a plant having altered floral morphology and a method for protecting plants against pest insects |
| 02/17/1994 | WO1994000572A3 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/17/1994 | WO1993025577A3 Active component of parathyroid hypertensive factor |
| 02/17/1994 | WO1993022332A3 Recombinant production of immunoglobulin-like domains in prokaryotic cells |
| 02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 02/17/1994 | DE4226868A1 Zubereitungen von Bakteriorhodopsin-Varianten mit erhöhter Speicherzeit und deren Verwendung Preparations of bacteriorhodopsin variants with increased storage time and their use |
| 02/17/1994 | DE4226373A1 Glyco-proteins derived from Halobacterium salinarium - useful in treatment and prophylaxis of diseases by non-specifically stimulating the immune system |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141940A1 Immunochemical assays for cancer-associated scm recognition factor |
| 02/17/1994 | CA2141785A1 Diamino acid derivatives as antihypertensives |
| 02/17/1994 | CA2141685A1 Antiallergic composition |
| 02/17/1994 | CA2141678A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | CA2141673A1 Non-peptidyl moiety-conjugated cd4-gamma2 and cd4-igg2 immunoconjugates, and uses thereof |
| 02/17/1994 | CA2141600A1 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 02/17/1994 | CA2141588A1 Parathyroid hormone fragments and analogs |
| 02/17/1994 | CA2141556A1 Morphogen-enriched dietary composition |
| 02/17/1994 | CA2141447A1 Conformationally restricted mimetics of reverse turns and peptides containing the same |
| 02/17/1994 | CA2141061A1 Peptides inhibiting ras protein activity, preparation and use thereof |
| 02/17/1994 | CA2140907A1 Anti-inflammatory peptide analogs and treatment to inhibit vascular leakage in injured tissues |
| 02/17/1994 | CA2140902A1 K. lactis transaldolase gene promoter and use thereof |
| 02/17/1994 | CA2139592A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/17/1994 | CA2119873A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enyzme for its preparation |
| 02/16/1994 | EP0583050A2 Recombinant stimulating factor of the neu receptor |
| 02/16/1994 | EP0582796A1 Promotor for expression and use thereof |